{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:43:18Z","timestamp":1792014198811,"version":"4.4.0"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"DOI":"10.3389\/fchem.2020.00406","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T10:34:37Z","timestamp":1591353277000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Insightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve NTS1-Induced Protective Hypothermia"],"prefix":"10.3389","volume":"8","author":[{"given":"Santo","family":"Previti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Vivancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"R\u00e9mond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Longpr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ballet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Sarret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florine","family":"Cavelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/0929867024606731","article-title":"Converting a peptide into a drug: strategies to improve stability and bioavailability","volume":"9","author":"Adessi","year":"2002","journal-title":"Curr. Med. Chem"},{"key":"B2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1749-6632.1982.tb31575.x","article-title":"Neurotensin and thermoregulation","volume":"400","author":"Bissette","year":"1982","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/262607a0","article-title":"Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin","volume":"262","author":"Bissette","year":"1976","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fendo.2013.00036","article-title":"Diverse roles of neurotensin agonists in the central nervous system","volume":"4","author":"Boules","year":"2013","journal-title":"Front Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.brainres.2009.10.050","article-title":"NT79: A novel neurotensin analog with selective behavioral effects","volume":"1308","author":"Boules","year":"2010","journal-title":"Brain Res"},{"key":"B6","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.4049\/jimmunol.162.8.4657","article-title":"Role of peptide backbone in T cell recognition","volume":"162","author":"Calbo","year":"1999","journal-title":"J. Immunol"},{"key":"B7","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1016\/S0021-9258(19)43429-7","article-title":"The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami","volume":"248","author":"Carraway","year":"1973","journal-title":"J. Biol. Chem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1021\/ja017440q","article-title":"Influence of silaproline on peptide conformation and bioactivity","volume":"124","author":"Cavelier","year":"2002","journal-title":"J. Am. Chem. Soc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/j.1471-4159.1984.tb05386.x","article-title":"Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase","volume":"43","author":"Checler","year":"1984","journal-title":"J Neurochem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1111\/j.1471-4159.1985.tb07220.x","article-title":"Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by a metalloendopeptidase","volume":"45","author":"Checler","year":"1985","journal-title":"J. Neurochem"},{"key":"B11","doi-asserted-by":"crossref","first-page":"11274","DOI":"10.1016\/S0021-9258(18)67379-X","article-title":"Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes","volume":"261","author":"Checler","year":"1986","journal-title":"J. Biol. Chem"},{"key":"B12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.pneurobio.2013.12.007","article-title":"Non-pharmaceutical therapies for stroke: mechanisms and clinical implications","volume":"115","author":"Chen","year":"2014","journal-title":"Prog Neurobiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1096\/fj.11-201822","article-title":"A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice","volume":"26","author":"Choi","year":"2012","journal-title":"FASEB J"},{"key":"B15","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1016\/S0021-9258(18)60678-7","article-title":"Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity","volume":"263","author":"Coy","year":"1988","journal-title":"J. Biol. Chem"},{"key":"B16","doi-asserted-by":"publisher","first-page":"18359","DOI":"10.1074\/jbc.270.31.18359","article-title":"Pharmacological and biochemical profiles of unique neurotensin 8-13 analogs exhibiting species selectivity, stereoselectivity, and superagonism","volume":"270","author":"Cusack","year":"1995","journal-title":"J. Biol. Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.peptides.2006.04.025","article-title":"Neurotensin and pain modulation","volume":"27","author":"Dobner","year":"2006","journal-title":"Peptides"},{"key":"B18","first-page":"30","article-title":"Reduced peptide bond pseudopeptide analogues of neurotensin","volume":"5","author":"Doulut","year":"1992","journal-title":"Pept. Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0014-2999(88)90699-1","article-title":"Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitors","volume":"151","author":"Dubuc","year":"1988","journal-title":"Eur. J. Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1523\/JNEUROSCI.19-01-00503.1999","article-title":"Identification of the receptor subtype involved in the analgesic effect of neurotensin","volume":"19","author":"Dubuc","year":"1999","journal-title":"J. Neurosci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1021\/jm200006c","article-title":"Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics","volume":"54","author":"Einsiedel","year":"2011","journal-title":"J. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1021\/acschemneuro.9b00390","article-title":"Neurotensin analogues containing cyclic surrogates of tyrosine at position 11 improve NTS2 selectivity leading to analgesia without hypotension and hypothermia","volume":"10","author":"Eiselt","year":"2019","journal-title":"ACS Chem. Neurosci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1021\/acs.jmedchem.5b00841","article-title":"Synthesis and characterization in vitro and in vivo of (L)-(trimethylsilyl)alanine containing neurotensin analogues","volume":"58","author":"Fanelli","year":"2015","journal-title":"J. Med. Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1021\/acs.jmedchem.6b01848","article-title":"Use of molecular modeling to design selective NTS2 neurotensin analogues","volume":"60","author":"Fanelli","year":"2017","journal-title":"J. Med. Chem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.pbb.2004.12.005","article-title":"Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys","volume":"80","author":"Fantegrossi","year":"2005","journal-title":"Pharmacol. Biochem. Behav"},{"key":"B26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuropharm.2009.07.001","article-title":"The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature","volume":"58","author":"Feifel","year":"2010","journal-title":"Neuropharmacology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2174\/1381612820666141027124915","article-title":"The roles of neurotensin and its analogues in pain","volume":"21","author":"Feng","year":"2015","journal-title":"Curr. Pharm. Des"},{"key":"B28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1432-1033.1982.tb05913.x","article-title":"Synthesis and characterization of neurotensin analogues for structure\/activity relationship studies","volume":"124","author":"Granier","year":"1982","journal-title":"Eur. J. Biochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.expneurol.2015.02.029","article-title":"Pharmacologically induced hypothermia attenuates traumatic brain injury in neonatal rats","volume":"267","author":"Gu","year":"2015","journal-title":"Exp. Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.neuropharm.2005.06.010","article-title":"Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues","volume":"49","author":"Hadden","year":"2005","journal-title":"Neuropharmacology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cmdc.201200376","article-title":"Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand","volume":"8","author":"Held","year":"2013","journal-title":"ChemMedChem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0960-894X(00)80698-8","article-title":"A structure-affinity study of the amino-acid side-chains in neurotensin - N and C-terminal deletions and ala-scan","volume":"3","author":"Henry","year":"1993","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/bc.bc_25_19","article-title":"Evidence and opportunities of hypothermia in acute ischemic stroke: clinical trials of systemic versus selective hypothermia","volume":"5","author":"Huber","year":"2019","journal-title":"Brain Circ"},{"key":"B34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0143-4179(84)90090-8","article-title":"Relationships between structure and duration of neurotensin's central action: emergence of long acting analogs","volume":"4","author":"Jolicoeur","year":"1984","journal-title":"Neuropeptides"},{"key":"B35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0006-8993(85)90031-9","article-title":"Microinjection of neurotensin into the ventral tegmental area produces hypothermia: evaluation of dopaminergic mediation","volume":"326","author":"Kalivas","year":"1985","journal-title":"Brain Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1553-2712.2001.tb01126.x","article-title":"Neurotensin analog NT69L induces rapid and prolonged hypothermia after hypoxic ischemia","volume":"8","author":"Katz","year":"2001","journal-title":"Acad. Emerg. Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"38564","DOI":"10.1038\/srep38564","article-title":"Structure and dynamics of a constitutively active neurotensin receptor","volume":"6","author":"Krumm","year":"2016","journal-title":"Sci. Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.2174\/0929867326666190506124836","article-title":"Therapeutic hypothermia and neuroprotection in acute neurological disease","volume":"26","author":"Kurisu","year":"2019","journal-title":"Curr. Med. Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1089\/neu.2013.3251","article-title":"Therapeutic effects of pharmacologically induced hypothermia against traumatic brain injury in mice","volume":"31","author":"Lee","year":"2014","journal-title":"J. Neurotrauma"},{"key":"B40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nbd.2016.09.013","article-title":"Regulation of therapeutic hypothermia on inflammatory cytokines, microglia polarization, migration and functional recovery after ischemic stroke in mice","volume":"96","author":"Lee","year":"2016","journal-title":"Neurobiol. Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/01616412.2016.1187826","article-title":"Pharmacological hypothermia: a potential for future stroke therapy?","volume":"38","author":"Liu","year":"2016","journal-title":"Neurol. Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0014-2999(91)90819-C","article-title":"Reduced peptide bond pseudopeptide analogues of neurotensin: binding and biological activities, and in vitro metabolic stability","volume":"205","author":"Lugrin","year":"1991","journal-title":"Eur. J. Pharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00726-019-02741-2","article-title":"Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids","volume":"51","author":"Magafa","year":"2019","journal-title":"Amino Acids"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0196-9781(02)00148-1","article-title":"Improvement of the enzymatic stability of a cytotoxic T-lymphocyte-epitope model peptide for its oral administration","volume":"23","author":"Marschutz","year":"2002","journal-title":"Peptides"},{"key":"B45","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0196-9781(80)90011-X","article-title":"Hypothermia elicited by the intracerebral microinjection of neurotensin","volume":"1","author":"Martin","year":"1980","journal-title":"Peptides"},{"key":"B46","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.euroneuro.2009.01.004","article-title":"Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice","volume":"19","author":"Mechanic","year":"2009","journal-title":"Eur. Neuropsychopharmacol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0006-8993(77)90173-1","article-title":"Neurotensin: central nervous system effects of a hypothalamic peptide","volume":"128","author":"Nemeroff","year":"1977","journal-title":"Brain Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1021\/jm801072v","article-title":"Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy","volume":"52","author":"Orwig","year":"2009","journal-title":"J. Med. Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1124\/jpet.300.1.305","article-title":"The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin","volume":"300","author":"Pettibone","year":"2002","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0006-8993(02)03271-7","article-title":"Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia","volume":"953","author":"Remaury","year":"2002","journal-title":"Brain Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.1021\/acs.chemrev.6b00122","article-title":"Silicon-containing amino acids: synthetic aspects, conformational studies, and applications to bioactive peptides","volume":"116","author":"R\u00e9mond","year":"2016","journal-title":"Chem. Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/7081_2015_177","article-title":"Silaproline, a silicon-containing proline surrogate","volume":"48","author":"R\u00e9mond","year":"2017","journal-title":"Top Heterocycl Chem"},{"key":"B53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00726-013-1492-2","article-title":"(L)-(Trimethylsilyl)alanine synthesis exploiting hydroxypinanone-induced diastereoselective alkylation","volume":"45","author":"Ren\u00e9","year":"2013","journal-title":"Amino Acids"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1124\/mol.60.6.1392","article-title":"Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2","volume":"60","author":"Richard","year":"2001","journal-title":"Mol. Pharmacol"},{"key":"B55","volume-title":"Peptide Analogs That are Potent and Selective for Human Neurotensin Receptor Subtype 2","author":"Richelson","year":"2008"},{"key":"B56","first-page":"1","article-title":"Neurotensin and its receptors","volume-title":"Reference Module in Neuroscience and Biobehavioral Psychology","author":"Sarret","year":"2018"},{"key":"B57","first-page":"229","article-title":"The role of neurotensin in central nervous system pathophysiology: what is the evidence?","volume":"31","author":"St-Gelais","year":"2006","journal-title":"J. Psychiatry Neurosci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1021\/jm00136a004","article-title":"Synthesis of peptides by the solid-phase method. 6. Neurotensin, fragments, and analogues","volume":"24","author":"St-Pierre","year":"1981","journal-title":"J Med Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-2007-1003601","article-title":"In vitro stability of growth hormone releasing factor (GRF) analogs in porcine plasma","volume":"23","author":"Su","year":"1991","journal-title":"Horm. Metab. Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fnins.2019.00586","article-title":"Neuroprotection by therapeutic hypothermia","volume":"13","author":"Sun","year":"2019","journal-title":"Front. Neurosci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-2999(99)00877-8","article-title":"Highly potent neurotensin analog that causes hypothermia and antinociception","volume":"390","author":"Tyler-McMahon","year":"2000","journal-title":"Eur. J. Pharmacol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0006-8993(77)90277-3","article-title":"Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes","volume":"130","author":"Uhl","year":"1977","journal-title":"Brain Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0165-6147(99)01357-7","article-title":"Neurotensin and neurotensin receptors","volume":"20","author":"Vincent","year":"1999","journal-title":"Trends Pharmacol. Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/(SICI)1099-0690(200003)2000:5<807::AID-EJOC807>3.0.CO;2-E","article-title":"Synthesis of Silaproline, a New Proline Surrogate","volume":"2000","author":"Vivet","year":"2000","journal-title":"Eur J Org Chem"},{"key":"B65","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuroscience.2013.07.052","article-title":"Acute and delayed protective effects of pharmacologically induced hypothermia in an intracerebral hemorrhage stroke model of mice","volume":"252","author":"Wei","year":"2013","journal-title":"Neuroscience"},{"key":"B66","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/cbic.201500312","article-title":"Peptide backbone composition and protease susceptibility: impact of modification type, position, and tandem substitution","volume":"17","author":"Werner","year":"2016","journal-title":"Chembiochem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature11558","article-title":"Structure of the agonist-bound neurotensin receptor","volume":"490","author":"White","year":"2012","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/0960-894X(95)00155-M","article-title":"Reduced amide bond neurotensin-8-13 mimetics with potent in-vivo activity","volume":"5","author":"Wustrow","year":"1995","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jphs.2017.10.004","article-title":"PD149163 induces hypothermia to protect against brain injury in acute cerebral ischemic rats","volume":"135","author":"Xue","year":"2017","journal-title":"J. Pharmacol. Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"113133","DOI":"10.1016\/j.expneurol.2019.113133","article-title":"Pharmacological hypothermia induced neurovascular protection after severe stroke of transient middle cerebral artery occlusion in mice","volume":"325","author":"Zhao","year":"2020","journal-title":"Exp. Neurol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14336\/AD.2019.0507","article-title":"Neuropsychological deficits chronically developed after focal ischemic stroke and beneficial effects of pharmacological hypothermia in the mouse","volume":"11","author":"Zhong","year":"2020","journal-title":"Aging Dis"}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fchem.2020.00406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T23:54:46Z","timestamp":1696204486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fchem.2020.00406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":71,"alternative-id":["10.3389\/fchem.2020.00406"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2020.00406","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"article-number":"406"}}